2oc8
From Proteopedia
(Difference between revisions)
m (Protected "2oc8" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
[[Image:2oc8.png|left|200px]] | [[Image:2oc8.png|left|200px]] | ||
- | <!-- | ||
- | The line below this paragraph, containing "STRUCTURE_2oc8", creates the "Structure Box" on the page. | ||
- | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
- | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
- | or leave the SCENE parameter empty for the default display. | ||
- | --> | ||
{{STRUCTURE_2oc8| PDB=2oc8 | SCENE= }} | {{STRUCTURE_2oc8| PDB=2oc8 | SCENE= }} | ||
===Structure of Hepatitis C Viral NS3 protease domain complexed with NS4A peptide and ketoamide SCH503034=== | ===Structure of Hepatitis C Viral NS3 protease domain complexed with NS4A peptide and ketoamide SCH503034=== | ||
- | |||
- | <!-- | ||
- | The line below this paragraph, {{ABSTRACT_PUBMED_17444623}}, adds the Publication Abstract to the page | ||
- | (as it appears on PubMed at http://www.pubmed.gov), where 17444623 is the PubMed ID number. | ||
- | --> | ||
{{ABSTRACT_PUBMED_17444623}} | {{ABSTRACT_PUBMED_17444623}} | ||
Line 22: | Line 11: | ||
==Reference== | ==Reference== | ||
- | <ref group="xtra">PMID: | + | <ref group="xtra">PMID:017444623</ref><ref group="xtra">PMID:008861917</ref><ref group="xtra">PMID:016087332</ref><ref group="xtra">PMID:016112859</ref><ref group="xtra">PMID:016112862</ref><ref group="xtra">PMID:016387495</ref><references group="xtra"/> |
[[Category: Hepatitis c virus]] | [[Category: Hepatitis c virus]] | ||
[[Category: Arasappan, A.]] | [[Category: Arasappan, A.]] |
Revision as of 13:00, 30 January 2013
Structure of Hepatitis C Viral NS3 protease domain complexed with NS4A peptide and ketoamide SCH503034
Template:ABSTRACT PUBMED 17444623
About this Structure
2oc8 is a 4 chain structure with sequence from Hepatitis c virus. Full crystallographic information is available from OCA.
Reference
- Prongay AJ, Guo Z, Yao N, Pichardo J, Fischmann T, Strickland C, Myers J Jr, Weber PC, Beyer BM, Ingram R, Hong Z, Prosise WW, Ramanathan L, Taremi SS, Yarosh-Tomaine T, Zhang R, Senior M, Yang RS, Malcolm B, Arasappan A, Bennett F, Bogen SL, Chen K, Jao E, Liu YT, Lovey RG, Saksena AK, Venkatraman S, Girijavallabhan V, Njoroge FG, Madison V. Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl] - 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimization. J Med Chem. 2007 May 17;50(10):2310-8. Epub 2007 Apr 20. PMID:17444623 doi:10.1021/jm060173k
- Kim JL, Morgenstern KA, Lin C, Fox T, Dwyer MD, Landro JA, Chambers SP, Markland W, Lepre CA, O'Malley ET, Harbeson SL, Rice CM, Murcko MA, Caron PR, Thomson JA. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell. 1996 Oct 18;87(2):343-55. PMID:8861917
- Arasappan A, Njoroge FG, Chan TY, Bennett F, Bogen SL, Chen K, Gu H, Hong L, Jao E, Liu YT, Lovey RG, Parekh T, Pike RE, Pinto P, Santhanam B, Venkatraman S, Vaccaro H, Wang H, Yang X, Zhu Z, Mckittrick B, Saksena AK, Girijavallabhan V, Pichardo J, Butkiewicz N, Ingram R, Malcolm B, Prongay A, Yao N, Marten B, Madison V, Kemp S, Levy O, Lim-Wilby M, Tamura S, Ganguly AK. Hepatitis C virus NS3-4A serine protease inhibitors: SAR of P'2 moiety with improved potency. Bioorg Med Chem Lett. 2005 Oct 1;15(19):4180-4. PMID:16087332 doi:10.1016/j.bmcl.2005.06.091
- Chen KX, Njoroge FG, Prongay A, Pichardo J, Madison V, Girijavallabhan V. Synthesis and biological activity of macrocyclic inhibitors of hepatitis C virus (HCV) NS3 protease. Bioorg Med Chem Lett. 2005 Oct 15;15(20):4475-8. PMID:16112859 doi:10.1016/j.bmcl.2005.07.033
- Bogen S, Saksena AK, Arasappan A, Gu H, Njoroge FG, Girijavallabhan V, Pichardo J, Butkiewicz N, Prongay A, Madison V. Hepatitis C virus NS3-4A serine protease inhibitors: use of a P2-P1 cyclopropyl alanine combination for improved potency. Bioorg Med Chem Lett. 2005 Oct 15;15(20):4515-9. PMID:16112862 doi:10.1016/j.bmcl.2005.07.009
- Bogen SL, Ruan S, Liu R, Agrawal S, Pichardo J, Prongay A, Baroudy B, Saksena AK, Girijavallabhan V, Njoroge FG. Depeptidization efforts on P3-P2' alpha-ketoamide inhibitors of HCV NS3-4A serine protease: effect on HCV replicon activity. Bioorg Med Chem Lett. 2006 Mar 15;16(6):1621-7. Epub 2006 Jan 4. PMID:16387495 doi:10.1016/j.bmcl.2005.12.013
Categories: Hepatitis c virus | Arasappan, A. | Bennett, F. | Beyer, B M. | Bogen, S L. | Chen, K. | Fischmann, T. | Girijavallabhan, V. | Guo, Z. | Hong, Z. | Ingram, R. | Jao, E. | Liu, Y T. | Lovey, R G. | Madison, V. | Malcolm, B. | Myers, J. | Njoroge, F G. | Pichardo, J. | Prongay, A J. | Prosise, W W. | Ramanathan, L. | Saksena, A K. | Senior, M. | Strickland, C. | Taremi, S S. | Venkatraman, S. | Weber, P C. | Yang, R S. | Yao, N. | Yarosh-Tomaine, T. | Zhang, R. | Hcv | Ketoamide inhibitor | Ns3 protease domain | Viral protein